Late occurring clinical deep vein thrombosis in joint-operated patients

被引:116
作者
Dahl, OE
Gudmundsen, TE
Haukeland, L
机构
[1] Ullevaal Univ Hosp, Dept Orthopaed, NO-0182 Oslo, Norway
[2] Ullevaal Univ Hosp, Res Forum, NO-0182 Oslo, Norway
[3] Buskerud Cent Hosp, Dept Radiol, Buskerud, Norway
[4] Buskerud Cent Hosp, Dept Orthopaed, Buskerud, Norway
来源
ACTA ORTHOPAEDICA SCANDINAVICA | 2000年 / 71卷 / 01期
关键词
D O I
10.1080/00016470052943883
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
In a prospective study of 4,840 patients, we determined the annual incidence of clinical deep vein thrombosis (DVT) in mobilized, discharged orthopedic-operated "high-risk" patients (hip replacement surgery, knee replacement surgery, nailed hip fracture) and assumed "low-risk" patients (diagnostic knee arthroscopy), In addition, the time from the operation to the time when the patients were readmitted with clinically suspected DVT and the distribution of radiologically-confirmed DVT were recorded. Thromboprophylaxis was routinely given for about 10 days to the high-risk groups during the hospital stay but not to patients undergoing knee arthroscopy. During 9 years, the annual incidence of DVT following major procedures was 2.1% (95% CI 1.6-2.6) vs. 0.6% (95% CI 0.2-1.1) after diagnostic knee arthroscopy, Symptoms appeared, on average, 27 (3-150) days after total hip replacement surgery, 36 (3-150) days after nailed hip fracture, 17 (6-30) days after total knee replacement and 1 (1-6) day after knee arthroscopy. In hip-operated patients, 50% of the DVT's were found in the proximal veins vs. 40% following knee arthroplasty.
引用
收藏
页码:47 / 50
页数:4
相关论文
共 27 条
[1]  
Alatri A, 1998, THROMB HAEMOSTASIS, V79, P234
[2]  
Andreassen G, 1997, Tidsskr Nor Laegeforen, V117, P2026
[3]   Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement [J].
Bergqvist, D ;
Benoni, G ;
Bjorgell, O ;
Fredin, H ;
Hedlundh, U ;
Nicolas, S ;
Nilsson, P ;
Nylander, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (10) :696-700
[4]   Commentary on thromboprophylaxis in hip replacement surgery [J].
Bulstrode, CJK .
ACTA ORTHOPAEDICA SCANDINAVICA, 1998, 69 (04) :343-344
[5]  
CAMPLIJNG EA, 1993, REPORT NATL CONFIDEN
[6]   Prevention of venous thromboembolism [J].
Clagett, GP ;
Anderson, FA ;
Geerts, W ;
Heit, JA ;
Knudson, M ;
Lieberman, JR ;
Merli, GJ ;
Wheeler, HB .
CHEST, 1998, 114 (05) :531S-560S
[7]   Screening for deep-venous thrombosis after hip and knee replacement without prophylaxis [J].
Clarke, MT ;
Green, JS ;
Harper, WM ;
Gregg, PJ .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1997, 79B (05) :787-791
[8]   INCREASED ACTIVATION OF COAGULATION AND FORMATION OF LATE DEEP VENOUS THROMBOSIS FOLLOWING DISCONTINUATION OF THROMBOPROPHYLAXIS AFTER HIP-REPLACEMENT SURGERY [J].
DAHL, OE ;
ASPELIN, T ;
ARNESEN, H ;
SELJEFLOT, I ;
KIERULF, P ;
RUYTER, R ;
LYBERG, T .
THROMBOSIS RESEARCH, 1995, 80 (04) :299-306
[9]  
Dahl OE, 1997, THROMB HAEMOSTASIS, V77, P26
[10]   FIBRIN FORMATION AND PLATELET-AGGREGATION IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION - EFFECTS OF INTRAVENOUS AND SUBCUTANEOUS LOW-DOSE HEPARIN [J].
GALLINO, A ;
HAEBERLI, A ;
HESS, T ;
MOMBELLI, G ;
STRAUB, PW .
AMERICAN HEART JOURNAL, 1986, 112 (02) :285-290